{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:46Z","timestamp":1791821026125,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11695-026-08508-5","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:14:53Z","timestamp":1771254893000},"page":"1377-1388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Metabolic and Bariatric Surgery Compared with GLP-1 Receptor Agonist Treatment in Preventing Mortality and Major Adverse Cardiac Events Among Individuals with Obesity and Type 2 Diabetes: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Joshua","family":"Chadwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandru","family":"Sivamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"N.L.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Ayyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganeshkumar","family":"Parasuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani Shankara","family":"Bagepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"10","key":"8508_CR1","first-page":"e71684","volume":"16","author":"L Saeed","year":"2024","unstructured":"Saeed L, Sharif G, Eda S, Tullimalli IR, Amin A, Riyalat AA, et al. Comparative effectiveness of bariatric metabolic surgery versus Glucagon-Like Peptide-1 receptor agonists on cardiovascular outcomes and mortality: a meta-analysis. Cureus. 2024;16(10):e71684.","journal-title":"Cureus"},{"key":"8508_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161521","volume":"14","author":"R Ruze","year":"2023","unstructured":"Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol. 2023;14:1161521.","journal-title":"Front Endocrinol"},{"issue":"5","key":"8508_CR3","first-page":"5","volume":"34","author":"D Dutta","year":"2024","unstructured":"Dutta D, Nagendra L, Joshi A, Krishnasamy S, Sharma M, Parajuli N. Glucagon-Like Peptide-1 receptor agonists in Post-bariatric surgery patients: A systematic review and Meta-analysis. Obes Surg 2024. 2024;34(5):5.","journal-title":"Obes Surg 2024"},{"key":"8508_CR4","doi-asserted-by":"crossref","unstructured":"Stenberg E, N\u00e4slund E. Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment. 2023;47(4).","DOI":"10.1038\/s41366-023-01254-z"},{"key":"8508_CR5","doi-asserted-by":"crossref","unstructured":"Wronka M, Krzemi\u0144ska J, M\u0142ynarska E, Rysz J, Franczyk B. New Insights into the Use of Liraglutide\u2014Impact on Cardiovascular Risk and Microvascular Outcomes. Biomedicines 2023, Vol 11, Page 1159. 2023;11(4):1159.","DOI":"10.3390\/biomedicines11041159"},{"issue":"Suppl 1","key":"8508_CR6","first-page":"S20","volume":"47","author":"Diagnosis and Classification of Diabetes","year":"2024","unstructured":"Diagnosis and Classification of Diabetes. Standards of care in Diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"1","key":"8508_CR7","first-page":"1","volume":"22","author":"M Moradi","year":"2022","unstructured":"Moradi M, Kabir A, Khalili D, Lakeh MM, Dodaran MS, Pazouki A, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study. BMC Endocr Disorders 2022. 2022;22(1):1.","journal-title":"BMC Endocr Disorders 2022"},{"issue":"1","key":"8508_CR8","first-page":"1","volume":"35","author":"I Meira","year":"2024","unstructured":"Meira I, Menino J, Ferreira P, Leite AR, Gon\u00e7alves J, Ferreira HU, et al. Diabetes remission after bariatric surgery: A 10-Year Follow-Up study. Obes Surg 2024. 2024;35(1):1.","journal-title":"Obes Surg 2024"},{"key":"8508_CR9","doi-asserted-by":"crossref","unstructured":"Zhou X, Zeng C. Diabetes remission of bariatric surgery and nonsurgical treatments in type 2 diabetes patients who failure to meet the criteria for surgery: a systematic review and meta-analysis. BMC Endocrine Disorders 2023;23(1):1\u20138.","DOI":"10.1186\/s12902-023-01283-9"},{"key":"8508_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1603670","volume":"12","author":"X Wei","year":"2025","unstructured":"Wei X, Yuan H, Wang D, Zhao J, Fang F. Effect of bariatric surgery on glycemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: a systematic review, meta-analysis, and meta-evidence of 39 studies. Front Nutr. 2025;12:1603670.","journal-title":"Front Nutr"},{"key":"8508_CR11","doi-asserted-by":"crossref","unstructured":"Gulinac M, Miteva DG, Peshevska-Sekulovska M, Novakov IP, Antovic S, Peruhova M et al. Long-term effectiveness, outcomes and complications of bariatric surgery. http:\/\/www.wjgnet.com\/. 2023;11(19):4504\u201312.","DOI":"10.12998\/wjcc.v11.i19.4504"},{"issue":"2","key":"8508_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/jbs.jbs_8_24","volume":"3","author":"M Bhandari","year":"2024","unstructured":"Bhandari M, Kosta S, Mathur W, Reddy M, Bhandari M, Neto MG. Single-center metabolic bariatric surgery experience study: outcomes from 21,205 cases over 12 years. J Bariatr Surg. 2024;3(2):69\u201378.","journal-title":"J Bariatr Surg"},{"key":"8508_CR13","doi-asserted-by":"crossref","unstructured":"Krishnan A, Schneider CV, Mukherjee D, Woreta TA, Alqahtani SA. Macrovascular outcomes and mortality after bariatric surgery in patients with metabolic dysfunction\u2013associated steatotic liver disease, and Type 2 diabetes. Diabetology & Metabolic Syndrome 2025 17:1. 2025;17(1):1\u201311.","DOI":"10.1186\/s13098-025-01767-9"},{"issue":"3","key":"8508_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/JS9.0000000000000066","volume":"109","author":"B Cui","year":"2023","unstructured":"Cui B, Wang G, Li P, Li W, Song Z, Sun X, et al. Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies. Int J Surg. 2023;109(3):389\u2013400.","journal-title":"Int J Surg"},{"issue":"3","key":"8508_CR15","first-page":"3","volume":"49","author":"N \u00c7al\u0131k Ba\u015faran","year":"2024","unstructured":"\u00c7al\u0131k Ba\u015faran N, Dotan I, Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. Int J Obes 2024. 2024;49(3):3.","journal-title":"Int J Obes 2024"},{"key":"8508_CR16","doi-asserted-by":"publisher","first-page":"1385510","DOI":"10.3389\/fnut.2024.1385510","volume":"11","author":"M C\u00f4t\u00e9","year":"2024","unstructured":"C\u00f4t\u00e9 M, Pelletier L, Nadeau M, Bouvet-Bouchard L, Julien F, Michaud A, et al. Micronutrient status 2 years after bariatric surgery: a prospective nutritional assessment. Front Nutr. 2024;11:1385510.","journal-title":"Front Nutr"},{"issue":"1","key":"8508_CR17","first-page":"1","volume":"87","author":"Y Jiao","year":"2024","unstructured":"Jiao Y, Liu Y, Chen S, Tang L. Zinc deficiency after bariatric surgery: A systematic review and Meta-analysis. Indian J Surg 2024. 2024;87(1):1.","journal-title":"Indian J Surg 2024"},{"issue":"6","key":"8508_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1001\/jamasurg.2025.1065","volume":"160","author":"S Wildisen","year":"2025","unstructured":"Wildisen S, Laager R, Struja T, Wildisen A, Mueller B, Schuetz P, et al. Major adverse cardiac events after gastric bypass vs sleeve gastrectomy. JAMA Surg. 2025;160(6):690\u2013700.","journal-title":"JAMA Surg"},{"issue":"10193","key":"8508_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019;394(10193):121\u201330.","journal-title":"Lancet"},{"key":"8508_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133683","volume":"440","author":"TG Rebelo","year":"2025","unstructured":"Rebelo TG, de Araujo Paysano MLB, Matheus GTFU, Ribeiro DM, Said TB, Kelly FA. Effects of oral semaglutide on cardiovascular outcomes: a systematic review and meta-analysis. Int J Cardiol. 2025;440:133683.","journal-title":"Int J Cardiol"},{"issue":"3","key":"8508_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030408","volume":"15","author":"AB Reiss","year":"2025","unstructured":"Reiss AB, Gulkarov S, Lau R, Klek SP, Srivastava A, Renna HA, et al. Weight reduction with GLP-1 agonists and paths for discontinuation while maintaining weight loss. Biomolecules. 2025;15(3):408.","journal-title":"Biomolecules"},{"key":"8508_CR22","doi-asserted-by":"crossref","unstructured":"Mousavi A, Shojaei S, Azarboo A, Bahri RA, Mohammadi S, Alilou S et al. The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after bariatric surgery: a systematic review and meta-analysis. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2025 30:1. 2025;30(1):1\u201316.","DOI":"10.1007\/s40519-025-01770-z"},{"key":"8508_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100679","volume":"18","author":"FB Rivera","year":"2024","unstructured":"Rivera FB, Cruz LLA, Magalong JV, Ruyeras JMMJ, Aparece JP, Bantayan NRB, et al. Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. Am J Prev Cardiol. 2024;18:100679.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"8508_CR24","first-page":"1","volume":"15","author":"H Zeng","year":"2025","unstructured":"Zeng H, Hu J, Zhuo Y, Wang M, Gao L, Tang Z, et al. Effect of GLP-1RA on coronary progression and cardiovascular outcomes in type 2 diabetic patients after PCI: a prospective cohort study. Sci Rep 2025. 2025;15(1):1.","journal-title":"Sci Rep 2025"},{"issue":"Supplement1","key":"8508_CR25","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.2337\/dc20-S009","volume":"43","author":"AD Association","year":"2020","unstructured":"Association AD. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142020. Diabetes Care. 2020;43(Supplement1):S98-110.","journal-title":"Diabetes Care"},{"issue":"8","key":"8508_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2024.0318","volume":"331","author":"AP Courcoulas","year":"2024","unstructured":"Courcoulas AP, Patti ME, Hu B, Arterburn DE, Simonson DC, Gourash WF, et al. Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes. JAMA. 2024;331(8):654\u201364.","journal-title":"JAMA"},{"key":"8508_CR27","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"key":"8508_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"8508_CR29","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M. PT. Newcastle-Ottawa Scale (NOS). Ottawa Hospital Research Institute [Internet]. [cited 2025 Dec 22]. Available from: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"issue":"8","key":"8508_CR30","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s41591-024-03052-0","volume":"30","author":"Y Wolff Sagy","year":"2024","unstructured":"Wolff Sagy Y, Lavie G, Ramot N, Battat E, Arbel R, Reges O, et al. Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nat Med. 2024;30(8):2337\u201342.","journal-title":"Nat Med"},{"issue":"6","key":"8508_CR31","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/dom.14992","volume":"25","author":"QYD Qi","year":"2023","unstructured":"Qi QYD, Playfair J, Brown WA, Burton P, O\u2019Brien PE, Wentworth JM. Long-term impact of weight loss for people with overweight but not obesity, and with type 2 diabetes: 10-year outcomes of a randomized trial of gastric band surgery. Diabetes Obes Metab. 2023;25(6):1464\u201372.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"8508_CR32","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s40618-022-01811-9","volume":"45","author":"J Ling","year":"2022","unstructured":"Ling J, Tang H, Meng H, Wu L, Zhu L, Zhu S. Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg\/m2: a multicenter propensity score-matched analysis. J Endocrinol Invest. 2022;45(9):1729\u201340.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"8508_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.soard.2021.11.019","volume":"18","author":"Z Ke","year":"2022","unstructured":"Ke Z, Zhou X, Sun F, Li F, Tong W, Zhu Z. Effect of bariatric surgery versus medical therapy on long-term cardiovascular risk in low BMI Chinese patients with type 2 diabetes: a propensity score-matched analysis. Surg Obes Relat Dis. 2022;18(4):475\u201383.","journal-title":"Surg Obes Relat Dis"},{"issue":"9997","key":"8508_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","volume":"386","author":"G Mingrone","year":"2015","unstructured":"Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964\u201373.","journal-title":"Lancet"},{"issue":"10271","key":"8508_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","volume":"397","author":"G Mingrone","year":"2021","unstructured":"Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293\u2013304.","journal-title":"Lancet"},{"issue":"6","key":"8508_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S2213-8587(15)00089-3","volume":"3","author":"S Ikramuddin","year":"2015","unstructured":"Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, et al. Roux-en-Y gastric bypass for diabetes (the diabetes surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3(6):413\u201322.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"8508_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae221","volume":"111","author":"E Stenberg","year":"2024","unstructured":"Stenberg E, Ottosson J, Cao Y, Sundbom M, N\u00e4slund E. Cardiovascular and diabetes outcomes among patients with obesity and type 2 diabetes after metabolic bariatric surgery or glucagon-like peptide 1 receptor agonist treatment. Br J Surg. 2024;111(9):znae221.","journal-title":"Br J Surg"},{"issue":"6","key":"8508_CR38","doi-asserted-by":"publisher","first-page":"E2415392","DOI":"10.1001\/jamanetworkopen.2024.15392","volume":"7","author":"D Dicker","year":"2024","unstructured":"Dicker D, Sagy YW, Ramot N, Battat E, Greenland P, Arbel R, et al. Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality. JAMA Netw Open. 2024;7(6):E2415392.","journal-title":"JAMA Netw Open"},{"key":"8508_CR39","doi-asserted-by":"crossref","unstructured":"Barrett TS, Hafermann JO, Richards S, LeJeune K, Eid GM. Obesity treatment with bariatric surgery vs GLP-1 receptor agonists. JAMA Surg. 2025;160(11).","DOI":"10.1001\/jamasurg.2025.3590"},{"key":"8508_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114564","volume":"282","author":"SE Messiah","year":"2025","unstructured":"Messiah SE, Ernest DK, Atem FD, Qureshi FG, Mathew MS, Francis JM, et al. Metabolic and bariatric surgery utilization in the era of Glucagon-Like Peptide-1 receptor agonists among adolescents versus adults. J Pediatr. 2025;282:114564.","journal-title":"J Pediatr"},{"issue":"1","key":"8508_CR41","first-page":"e52796","volume":"16","author":"M Elsaigh","year":"2024","unstructured":"Elsaigh M, Awan B, Shabana A, Sohail A, Asqalan A, Saleh O, et al. Comparing safety and efficacy outcomes of gastric bypass and sleeve gastrectomy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Cureus. 2024;16(1):e52796.","journal-title":"Cureus"},{"issue":"8","key":"8508_CR42","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1007\/s11695-025-08044-8","volume":"35","author":"L Monteiro Delgado","year":"2025","unstructured":"Monteiro Delgado L, Fabretina de Souza V, Fontel Pompeu B, de Moraes Ogawa T, Pereira Oliveira H, Sacksida Vallad\u00e3o VdaC, et al. Long-Term outcomes in sleeve gastrectomy versus Roux-en-Y gastric bypass: A systematic review and Meta-Analysis of randomized trials. Obes Surg. 2025;35(8):3246\u201357.","journal-title":"Obes Surg"},{"issue":"9","key":"8508_CR43","first-page":"101","volume":"54","author":"M SP","year":"2016","unstructured":"SP M, GH D, K BF PK, JF M, MA N, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. Drug Ther Bull. 2016;54(9):101.","journal-title":"Drug Ther Bull"},{"issue":"11","key":"8508_CR44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"10","key":"8508_CR45","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jacc.2019.12.063","volume":"75","author":"SP Marso","year":"2020","unstructured":"Marso SP, Baeres FMM, Bain SC, Goldman B, Husain M, Nauck MA, et al. Effects of liraglutide on cardiovascular outcomes in patients with diabetes with or without heart failure. J Am Coll Cardiol. 2020;75(10):1128\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"10402","key":"8508_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402(10402):613\u201326.","journal-title":"Lancet"},{"issue":"3","key":"8508_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"6","key":"8508_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Fr\u00edas","year":"2021","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, P\u00e9rez Manghi FC, Fern\u00e1ndez Land\u00f3 L, Bergman BK, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503\u201315.","journal-title":"N Engl J Med"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08508-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:22:17Z","timestamp":1774963337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08508-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8508"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08508-5","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}